📰 Relevant Persons News
Page 36 - Relevant Persons News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Relevant Persons. Real-time updates on events, politics, business and more.
December 20, 2022
EQS-Ad-hoc: European Healthcare Acquisition & Growth Company B.V. / Key word(s): Miscellaneous European Healthcare Acquisition & Growth Company B.V. and Croma-Pharma GmbH in advanced discussions
December 14, 2022
EQS-News: Cantourage Group SE / Key word(s): Product Launch/Market Launch Cantourage Group SE: Most potent cannabis flower on the Ger...
December 8, 2022
Investegate announcements from clearvise AG, clearvise AG successfully completes rights issue
December 7, 2022
Investegate announcements from clearvise AG, clearvise AG records subscription rate of at least 81.7% in capital increase
December 6, 2022
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA
December 1, 2022
Not for release or distribution, directly or indirectly, in or into the United States of America, Australia, Canada or Japan or any other jurisdiction where such release or distribution would
November 29, 2022
Not for release or distribution, directly or indirectly, in or into the United States of America, Australia, Canada or Japan or any other jurisdiction where such release or distribution would
November 29, 2022
ALD ALD: Announcement 29-Nov-2022 / 06:45 CET/CEST Dissemination of a French Regulatory News, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. ... | November 29, 2022
November 29, 2022
DJ ALD: Announcement ALD ALD: Announcement 29-Nov-2022 / 06:45 CET/CEST Dissemination of a French Regulatory News, transmitted by EQS Group. The issuer is solely responsible for the content of
November 23, 2022
EQS-News: Vivoryon Therapeutics N.V. / Key word(s): Miscellaneous Vivoryon Therapeutics N.V.: Vivoryon Therapeutics Announces Success...